Latest Stock Market News

Indian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump s executive order. The order aims to boost domestic drug production in the United States. Concerns arose about potential disruptions for Indian drug exporters. These exporters heavily rely on the US market. The Nifty Pharma index saw a drop. Companies like Lupin, Aurobindo Pharma, and Cipla faced losses.

Gold prices surged on Tuesday due to concerns over President Trump s proposed tariffs, increasing safe-haven demand. Investors are keenly awaiting the Federal Reserve s policy meeting for insights into future rate adjustments, especially with the current rate held steady since last December. Spot gold rose significantly, alongside silver and other metals, reflecting market uncertainty.

When the RSI value crosses above 50 from below, it signals that the Relative Strength Index (RSI) is rising, indicating strengthening momentum in the stock s price. This suggests a potential upward trend.

Explore the promising landscape of India s defense sector, driven by strategic government initiatives and robust growth potential. Discover key players and their performance metrics as the sector gears up for a transformative era.

The Nifty Pharma index was trading 0.88 per cent down at 21585.05.

CCL Products shares soared nearly 16% following a robust January-March quarter. The company s net profit jumped 56.35% to Rs 101.9 crore. Revenue grew 15% to Rs 836 crore, driven by exports and Vietnam facility output. EBITDA rose 38.3% to Rs 163.3 crore. Analysts predict an 11% upside, with a Buy recommendation. The stock surged 23% in one month.

April saw EPS downgrades for 70% of Nifty50 firms, led by Zomato with a 15.1% cut. IT, consumer, and auto sectors faced sharp estimate reductions. Despite strong Q4 beat-miss ratios, FY26 forecasts declined due to global headwinds and underperformance in IT, FMCG, and financials.

Following the Pahalgam attack, Pakistan s KSE-100 index fell nearly 4%. Fears of military escalation rattled investors. India s Sensex rose 1.5%, defying regional risks. Moody s warned of economic strain on Pakistan. India suspended the Indus Waters Treaty. Foreign investors remained confident in India. Tensions between the two countries remain high. The historical context shows Indian markets have weathered such tensions.

Pankaj Pandey suggests markets will likely recover from geopolitical shocks within months, maintaining a positive outlook for banks and oil & gas as foreign selling pressure eases. While cautioning against the sell in May adage, Pandey highlights potential near-term volatility. He sees opportunities in commodities, hotels, hospitals, autos, AMCs and real estate, favoring a stock-picking approach.

Ray Dalio, who predicted the 2008 financial crisis, warns the U.S. faces economic peril worse than a recession. He attributes this to rising debt, political instability, and Trump s tariffs, which disrupt the global order. Dalio urges fiscal discipline to avert a potential collapse of the dollar and increased global tensions, drawing parallels to the instability of the 1930s.